Literature DB >> 26277566

Metronidazole-but not IL-10 or prednisolone-rescues Trichuris muris infected C57BL/6 IL-10 deficient mice from severe disease.

Jamie J Kopper1, Jon S Patterson2, Linda S Mansfield3.   

Abstract

Trichuris muris infected C57BL/6 mice are a frequently studied model of immune mediated resistance to helminths. Our objective was to characterize dose-dependent gastrointestinal (GI) disease and pathology due to Trichuris in C57BL/6 mice with varying degrees of IL-10 sufficiency. These mice can serve as a model for other animals (dogs, cattle) and humans where IL-10 polymorphisms have been associated with disease susceptibility and may affect susceptibility to whipworm. C57BL/6 IL-10(+/+), IL-10(+/-) and IL-10(-/-) mice were infected with T. muris (J strain) in a dose response study. T. muris produced dose-dependent disease in IL-10(-/-) mice. Ninety percent of mice receiving the high dose (75 ova) had severe disease necessitating early euthanasia, while the medium dose (50 ova) resulted in 100% early euthanasia of males/75% of females, and the low dose (25 ova) in 100% early euthanasia of males/25% of females. Having some IL-10 as in heterozygotes did not rescue all infected mice from effects of the high dose. 2/21 IL-10(-/-), 1/17 IL-10(+/-), and 0/17 IL-10(+/+) mice in the high dose group had severe peritonitis and extra-intestinal bacteria confirmed by fluorescent 16S rDNA analysis of peritoneal organ surfaces. Three of twenty one IL-10(-/-) had demonstrable extra-intestinal T. muris adults. Although free from viral pathogens, 12/21 IL-10(-/-), 6/17 IL-10(+/-), and 4/17 IL-10(+/+) infected mice had hepatitis, while control mice of all genotypes did not. Mice had evidence of inflammation of serosal surfaces of liver, spleen and GI tract even when extraintestinal Trichuris were not found. Blinded histopathology scoring revealed that even when infected IL-10(-/-) mice displayed few, if any, clinical signs, levels of gut inflammation did not vary significantly from those mice euthanized early due to severe disease. To examine whether antibiotics or corticosteroids could reverse severe disease and lesions, IL-10(-/-) mice infected with T. muris were treated with metronidazole or prednisolone prior to and throughout 40 days of infection. Mice given prednisolone had severe disease and lesions with the highest mortality rate. Mice given metronidazole had a significantly lower mortality rate than those given prednisolone, but GI lesions were of similar severity and distribution including peritonitis. Mortality was associated with extraintestinal worms and bacteria and further supported a role for enteric bacteria in this pathogenesis.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C57BL/6 mice; IL-10 deficiency; Metronidazole and prednisolone; Trichuris muris

Mesh:

Substances:

Year:  2015        PMID: 26277566     DOI: 10.1016/j.vetpar.2015.07.038

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  3 in total

1.  Pre-clinical evaluation of the effect of co-medication with antibiotics and oral steroids in Göttingen Minipigs on the biological activity of the probiotic medicinal product TSO (Trichuris suis ova).

Authors:  M V Prosberg; H Kringel; J S Kapel; B S Kapel; B L Fredensborg; A M Petersen; L H Hansen; D S Nielsen; H S Kapel; K R Jacobsen; L F Mikkelsen; C M O Kapel
Journal:  Parasitol Res       Date:  2021-01-06       Impact factor: 2.289

2.  Exclusive dependence of IL-10Rα signalling on intestinal microbiota homeostasis and control of whipworm infection.

Authors:  María A Duque-Correa; Natasha A Karp; Catherine McCarthy; Simon Forman; David Goulding; Geetha Sankaranarayanan; Timothy P Jenkins; Adam J Reid; Emma L Cambridge; Carmen Ballesteros Reviriego; Werner Müller; Cinzia Cantacessi; Gordon Dougan; Richard K Grencis; Matthew Berriman
Journal:  PLoS Pathog       Date:  2019-01-14       Impact factor: 6.823

3.  Trichuris muris and comorbidities - within a mouse model context.

Authors:  Kelly S Hayes; Richard K Grencis
Journal:  Parasitology       Date:  2021-06-03       Impact factor: 3.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.